Rene Y. McNall-Knapp, MD

Rene Y. McNall-Knapp, MD, is a pediatric hematologist-oncologist at Jimmy Everest Center at Oklahoma Children’s Hospital OU Health and professor in the Department of Pediatrics at the University of Oklahoma Health Sciences Center.

Articles by Rene Y. McNall-Knapp, MD

Rene Y. McNall-Knapp, MD, a pediatric hematologist-oncologist at the Jimmy Everest Center at Oklahoma Children’s Hospital Oklahoma University Health

Dr McNall-Knapp on the Efficacy of MEK Inhibition in NF1-Associated PNs

ByRene Y. McNall-Knapp, MD

April 24th 2025

Rene Y. McNall-Knapp, MD, discusses the current treatment paradigm for pediatric and adult patients with NF1-associated PNs.

Rene Y. McNall-Knapp, MD, pediatric hematologist-oncologist, Jimmy Everest Center, Oklahoma Children’s Hospital OU Health; professor, Department of Pediatrics, University of Oklahoma Health Sciences Center

Dr McNall-Knapp on HRQOL Outcomes With Mirdametinib in NF1-PN

ByRene Y. McNall-Knapp, MD

February 10th 2025

Rene Y. McNall-Knapp, MD, discusses HRQOL outcomes from the ReNeu trial investigating mirdametinib in patients with NF1-PN.

Rene Y. McNall-Knapp, MD

Articles by Rene Y. McNall-Knapp, MD

Dr McNall-Knapp on the Efficacy of MEK Inhibition in NF1-Associated PNs

Dr McNall-Knapp on HRQOL Outcomes With Mirdametinib in NF1-PN

Latest Updated Articles

Trending on OncLive

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies

Nuvisertib Yields Strong Safety, Promising Efficacy in R/R Myelofibrosis

FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL